Related Experiment Videos
DNA immunomodulation of asthma.
Joel N Kline1, Zuhair K Ballas
1University of Iowa College of Medicine, Iowa City, Iowa, USA.
Clinical Allergy and Immunology
|October 2, 2001
Summary
Current asthma and allergy treatments manage symptoms, not causes. Immunotherapy and novel DNA-based strategies show promise for reversing the atopic state by targeting underlying mechanisms.
Area of Science:
- Allergy and immunology
- Respiratory medicine
- Genetics
Background:
- Asthma and allergic diseases have advanced treatment options.
- Most current therapies target symptoms, not underlying disease mechanisms.
- Immunotherapy is the only treatment addressing underlying mechanisms, but its effects are not fully understood.
Purpose of the Study:
- To explore novel therapeutic strategies for asthma and allergic diseases.
- To discuss the potential of immunotherapy and DNA-based approaches.
- To highlight future research directions based on genomic insights.
Main Methods:
- Review of current literature on asthma and allergy treatments.
- Discussion of immunotherapy's role and mechanisms.
- Exploration of novel DNA-based therapeutic approaches, including allergen DNA with CpG.
- Consideration of genomic research, specifically targeting Th2 cytokines on chromosome 5.
Main Results:
- Immunotherapy offers a mechanism-based approach to allergic diseases.
- Novel DNA-based strategies are emerging as potential treatments.
- Understanding cytokine regulation at the chromosomal level presents new research avenues.
Conclusions:
- Future treatments may reverse the atopic state through immunotherapy or DNA-based methods.
- Genomic research, particularly on chromosome 5 and Th2 cytokines, holds promise for controlling allergic diseases.
- A combination of approaches may be necessary for effective disease reversal.